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Supplemental Materials and Methods
Virtual Screening
The atomic interactions between RhoA and LARG were obtained from PDB ID 1X86 (Kristelly et al., 2004) . Redundant objects were removed leaving chain A (LARG) and chain B (RhoA). The complex was repaired by adding missing atoms, assigning correct bond orders and resonance, and predicting pKa values of exposed residues at pH 7.4 and 0.9% NaCl (Krieger et al., 2006) . One iteration of backbone-restrained energy minimization was followed by full energy minimization in explicit solvent using the AMBER99 force field and the Particle Mesh Ewald method for treatment of long-range electrostatics (cutoff 7.2 A) using YASARA (Krieger et al., 2004) .
After the protein complex was repaired, LARG was removed and the interaction surface with
RhoA examined in order to identify reasonable small molecule binding sites. This is a qualitative process that involves looking for concave surfaces with relatively low thermodynamic motion (low beta factor), and a relatively high density of protein:protein interactions. The concave surface to either side RhoA Trp58 meets these criteria and was chosen as the binding site for virtual screening. Tryptophan is known to be a key mediator of protein:protein interactions (Uttamkumar and Chakrabarti, 2001) thus Trp58 was chosen as the center of search space. Trp58 is not in and of itself part of a surface concavity however it is immediately flanked on two sides by concave surfaces (~500 Å3 and ~1200 Å3) that contain several polar inter-protein contacts (LARG LYS-939 and RhoA ASP-59, LARG THR-938 and RhoA GLY-62) involved in the interaction between LARG:RhoA.
The in silico compound library was derived from the ZINC purchasable (International Zinc Association -America, Washington, DC) compound set. Single molecules were used to create conformers using OMEGA at default settings (OpenEye Scientific Software). The conformer library was screened across the W58 binding site using FRED, rigid ligand and receptor, default scoring (OpenEye Scientific Software), in parallel mode on an SGI Altix 4700 computer. The top 1000 hits were submitted for flexible-ligand, rigid-receptor docking and energy minimization using Molegro, default scoring (Molegro ApS). The top 100 compounds were selected and the top 49 were obtained for testing.
Recombinant Protein Production
Recombinant human LARG (residues 765-1138) containing the DH-PH catalytic module , human 
Western blot analysis
For western blot analysis, cell lysates or co-precipitates were separated in 4 -15 % gradient SDS-PAGE and transferred onto PVDF membrane (Bio-Rad, Hercules, CA). The membranes were blocked with 1% BSA in TBS-T (20mM Tris-HCl, pH 7.6, 150 mM NaCl, and 0.1% Tween 20)
for 1 hour at room temperature, and probed with primary antibodies followed by horse radishperoxidase coupled (HRP) secondary antibody for enhanced chemiluminescence analysis (Thermo 
Cell Cytotoxicity Assay
NIH3T3 cells were treated in the presence or absence of G04 at the indicated concentration and then subjected to PI/RNase staining (BD Biosciences, San Diego, CA) followed by FACS analysis.
Cell apoptosis was measured by AnnexinV-FITC and 7AAD (BD Biosciences, San Diego, CA) staining followed by FACS.
Cell Proliferation Assay
The growth rates of the MCF cells in the presence of G04 were determined. Briefly, 1.5 ×10 4 cells were plated in 24-well plates in the presence of 10% FBS. Cell numbers at different time points were determined using a hemocytometer.
Cell Adhesion Assay
Twenty-four-well plates were coated with fibronectin (Sigma, St. Louis, MO) at 10 g/mL concentration for overnight at 4°C. The wells were rinsed for two times with PBS and blocked with 2% BSA for 30 min at room temperature, followed by three additional rinses with PBS.
NIH3T3 cells were pre-treated with G04 at 30 M for 24 hours. Cells (2× 10 4 cells/Well) were then plated into each well in DMEM medium containing 10% calf serum and were allowed to attach for 10, 30 45 or 60 minutes in the presence of G04 at 30 M. Non-adherent cells were removed by three washes with PBS, and the attached cells were harvested by trypsin-EDTA(0.05%) treatment.
Non-specific adhesion was taken into account by measurement of adherent cells on BSA-coated wells.
Cell Invasion Assay
Cell invasion assays were performed using the 6.4-mm Biocoat Matrigel invasion chambers equipped with the 8.0-m pore sized PET membrane filters (BD Biosciences, San Jose, CA)
according to the manufacturer's instructions. Briefly, 2.5 x 10 4 cells were suspended in 0.5 ml of culture medium and were plated in the upper chamber. 10% FBS in the culture medium was added to the lower chamber as a chemo-attractant. Cells in the invasion chambers were incubated in a humidified incubator (37 o C and 5% CO 2 ) for 16 hours. The cells that traversed the Matrigel matrix and the 8.0-m membrane pores and spread to the lower surface of the filters were stained with 5%
Giemsa solution for visualization and cell number quantification. The relative invasion index was normalized by dividing the invaded cell number of each sample by that of the HME non-treated control. Each data point of the invasion test was derived from triplicate chambers, and error bars represent the mean standard error.
MCF7 and MCF10A Cell Mammosphere Culture
Mammosphere culture was performed as described (Dontu et al., 2003) . The MCF7 and MCF10A cells were dissociated to single cells with trypsin and were cultured for 10 days at the density of 2^10 4 /mL in the presence of G04 at the indicated concentration. Photos were taken after 10-day's culture. Images shown are representative of five to ten fields containing a total of at least 100 spheres which were chosen randomly. The average size of mammary sphere were measured and calculated relative to the control.
Morphometric analysis of neurite outgrowth
PC12 cells were grown in Dulbecco's modified Eagle's medium (DMEM) with 5% fetal calf serum and 10% horse serum. The cells were treated with 30 M G04 and 50 ng/mL NGF for 72 days. Photos were taken at indicated time points. Relative neurite length per cell were measured.
Five to eight fields containing a total of at least 100 cells were chosen randomly. Elongations longer than one cell body were considered neurites. Total neurite output was determined by dividing the combined length of all neurites by the number of neurite-bearing cells.
Mass spectrometry assay
